Skip to main content
. 2022 Feb 2;23:105. doi: 10.1186/s13063-021-05988-x

Table 1.

Summary of the analysis plan

Variables Intention-to-treat cohort Per-protocol cohort
Baseline characteristics No statistical comparisons None
Intervention and co-interventions Chi-square, Fisher’s exact test, Wilcoxon–Mann–Whitney test, t-test as applicable None
Primary outcome

1. Primary analysis: chi-square or Fisher’s exact test. Report relative risk.

2. Secondary analyses: unadjusted Cox proportional analysis, KM curves, adjusted logistic regression

1. Primary analysis: chi-square or Fisher’s exact test. Report relative risk.

2. Secondary analyses: unadjusted Cox proportional analysis, KM curves, adjusted logistic regression

Secondary outcomes-categorical Chi-square or Fisher’s exact test. Report relative risk Chi-square or Fisher’s exact test. Report relative risk
Secondary outcomes-continuous Generalized linear mixed models. Report beta estimate Generalized linear mixed models. Report beta estimate
Safety outcomes and other variables Chi-square or Fisher’s exact test. Report relative risk. For serial measurements, generalized linear mixed effect models None
Subgroup analyses Chi-square or Fisher’s exact test. Report relative risk. Tests of interaction None
180-day follow-up

Chi-square or Fisher’s exact test for 180-day mortality. Report relative risk

Generalized linear mixed models for EQ-5D-5L ad VAS. Report beta estimate

Chi-square or Fisher’s exact test for 180-day mortality. Report relative risk

Generalized linear mixed models for EQ-5D-5L ad VAS. Report beta estimate